Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients

The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats

(2009) Charles Henley et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cinacalcet and achievement of the NKF/K-DOQITM recommended target values for bone and mineral metabolism in real-world clinical practice--the ECHO observational study

(2009) P. Urena et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE−/−) mice

(2008) Ognen Ivanovski et al.   ATHEROSCLEROSIS

The OPTIMA Study: Assessing a New Cinacalcet (Sensipar/Mimpara) Treatment Algorithm for Secondary Hyperparathyroidism

(2008) P. Messa et al.   Clinical Journal of the American Society of Nephrology

Cinacalcet HCl and Concurrent Low-dose Vitamin D Improves Treatment of Secondary Hyperparathyroidism in Dialysis Patients Compared with Vitamin D Alone: The ACHIEVE Study Results

(2008) S. Fishbane et al.   Clinical Journal of the American Society of Nephrology

Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism

(2008) G. A. Block et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION